Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Monomer Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
Monomer Bio

Monomer Bio

Seed

Monomer Bio: Expert lab automation services from a passionate team, offering custom-built solutions for biology companies.

HQ
Pacifica, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Monomer Bio was founded by a team of experts from Google, MIT, Strateos, and UPenn with a mission to revolutionize lab automation for biology companies. Their vision is to create the first scientifically-aware lab automation platform that seamlessly integrates instruments and software. Monomer Bio offers services ranging from consultation on instrument purchases to custom-built software and hardware solutions, aimed at enhancing the efficiency and capabilities of biological research labs.

The team at Monomer Bio includes notable professionals who have previously built some of the world's largest fully automated labs. Their expertise has attracted significant attention and investment from key players in the biotech industry. Monomer Bio's impact is evident in its ability to streamline lab operations, making advanced research more accessible and efficient for biology companies.

Monomer Bio - Similar Companies

BioNex Solutions logo

BioNex Solutions

AbioBot logo

AbioBot

abiobot.io

AvanSci Bio logo

AvanSci Bio

avanscibio.com

Clickbio logo

Clickbio

click-bio.com

Opentrons logo

Opentrons

opentrons.com

New Lab logo

New Lab

Aqueduct Fluidics logo

Aqueduct Fluidics

Strateos logo

Strateos

strateos.com

Artificial logo

Artificial

artificial.com

Scispot logo

Scispot

scispot.io

Insightful Science logo

Insightful Science

Hardin Scientific logo

Hardin Scientific

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Monod Bio logo

Monod Bio

monod.bio

Dashlabs.ai logo

Dashlabs.ai

dashlabs.ai

Monomer Bio - Quick Facts

Who are Monomer Bio's competitors?

Companies similar to Monomer Bio include BioNex Solutions, AbioBot, AvanSci Bio and Clickbio.

When was Monomer Bio founded?

Monomer Bio was founded in 2021.

Where is Monomer Bio's headquarters located?

Monomer Bio's headquarters is located in Pacifica, CA, US.

When was Monomer Bio's last funding round?

Monomer Bio's most recent funding round was for $5.6M (USD) in January 2024.

How much has Monomer Bio raised to-date?

As of Jan 31, 2024, Monomer Bio has raised a total of $5.6M (USD).

How many employees does Monomer Bio have?

Monomer Bio has 7 employees as of Feb 4, 2024.

Monomer Bio - Classification

Industry
  • Professional Service Companies
Ownership
  • Venture Capital
Technology
  • AI
  • Automation
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Lab Automation
Tags
  • AI Operations
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software